Researchers studied mitochondrial dynamics to treat Parkinson disease | Current Affairs | Vision IAS
News Today Logo

Researchers studied mitochondrial dynamics to treat Parkinson disease

Posted 02 Sep 2024

2 min read

Parkinson’s disease is a neurodegenerative disease caused by the death of brain cells.

  • Presence of environmental toxins and toxic proteins, causes fragmentations and dysfunctions in mitochondria.  E.g. Manganese induced Parkinsonism.
  • Researchers have found that inhibiting Dynamin-related protein (Drp1) activity could restore mitochondrial function and serve as a potential treatment. 
    • Naturally abundant in cells, Drp1 protein travels to mitochondria when they divide into smaller sizes for higher mobility and quality control. 
    • However, too much Drp1 activity causes excessive division, leading to fragmented mitochondria with impaired function.

Mitochondria

  • Mitochondria are membrane-bound cell organelles that generate most of the cell's energy in the form of ATP (adenosine triphosphate).
  • Functions
    • Energy Production: Sites of aerobic respiration, producing ATP, hence termed the power houses of the cell.
    • Genetic Material: Contains its own circular DNA (Mitochondrial DNA or mtDNA), RNA, ribosomes, and components for protein synthesis. 
      • mtDNA is useful for tracing genetic lines.

Mitochondrial Diseases

  • These are caused by genetic mutation of mtDNA or nuclear DNA. 
    • mtDNA is inherited exclusively from the mother, making these diseases maternally inherited.
    • Mitochondrial Replacement Therapy (MRT) prevents the transmission of mitochondrial diseases from mother to child.

 

  • Tags :
  • Mitochondria
  • Parkinson's Disease
Watch News Today